A recent study published in Quaternary Research describes the discovery and identification of possible aardvark tracks and ...

We recently published a list of Top 10 Insider Purchases Last Month. In this article, we are going to take a look at where ...

Cantor Fitzgerald initiated coverage of Aardvark Therapeutics (AARD) with an Overweight rating and $50 price target Aardvark is developing ...

Morgan Stanley initiated coverage of Aardvark Therapeutics (AARD) with an Overweight rating and $29 price target The firm believes the Phase 2 ...

We recently published a list of 10 Stocks With At Least $10 Million In Insider Spending Recently. In this article, we are ...

Equities research analysts at Cantor Fitzgerald issued their FY2024 earnings per share (EPS) estimates for Aardvark Therapeutics in a report released on Monday, March 10th. Cantor Fitzgerald analyst J ...

Investment analysts at Bank of America began coverage on shares of Aardvark Therapeutics (NASDAQ:AARD – Get Free Report) in a note issued to investors on Monday, MarketBeat reports. The firm set a ...

The miraculous rescue of elderly Rosalia De Giosa was met with an emotional round of applause from onlookers in Via De Amicis ...

The Middle is a sitcom that gives you reason to find any of the central family's children annoying, but many seem to be ...

On Monday, RBC Capital initiated coverage on Aardvark Therapeutics Inc (NASDAQ:AARD), awarding the stock an Outperform rating and setting a price target of $21.00. The stock, currently trading at ...

In this article, we are going to take a look at where Aardvark Therapeutics, Inc. (NASDAQ:AARD) stands against other stocks with at least $10 million in insider spending recently. Since Donald ...